Veeva Systems shares were 7% higher, at $235.89, after the company said its board of directors approved a share-repurchase program with authorization to buy up to $2 billion of its shares.

Veeva Systems Inc. (NYSE: VEEV), a leading provider of industry cloud solutions for the global life sciences industry, today ...

Systems announced that its board of directors approved a share repurchase program with authorization to purchase up to $2B of shares ...

The life sciences cloud solutions provider said its Board of Directors has authorized the buyback of up to $2 billion of its Class A common stock over a two-year period. The company plans to execute ...

Veeva Systems (VEEV) is back in focus for investors after fresh attention on its role providing cloud software to global life sciences clients, prompting a closer look at how the stock's recent moves ...

Veeva Systems has unveiled its first big biotech pact since thawing relations with one-time adversary IQVIA, teaming up with Amgen to find ways to improve clinical trial processes. Amgen will take ...

Despite recent volatility and challenges, Veeva Systems Inc. holds a bullish outlook for the near term, with confidence in a rebound and strong growth potential. Veeva's fiscal 2025 guidance projects ...

This cloud-based company took advantage of its first-ever public earnings report to make a great impression. While matching earnings expectations, Veeva blew past analyst expectations of $50 million ...

Veeva Systems, which provides cloud-based healthcare software, inked a deal with the biopharma UCB aimed at improving the patient experience in digital clinical trials. Under the agreement, UCB will ...

How do you create a culture that revolves around speed at a company with 7,000 employees across more than 40 countries? To learn, I met with Vivian Welsh, the chief people officer (CPO) of Veeva ...